Advisors Inner Circle Fund - Cambiar Aggressive Value ETF (CAMX) Stock Price

31.714 ▼ -0.45 (-1.40%)
Open: 31.714 Vol: 61 Day's range: 31.714 - 31.714 Dec 30, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CAMX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 32.15▲ 32.18▲ 32.18▲ 32.09▼ 32.13▼
MA10 31.92▲ 31.76▲ 31.76▲ 32.11▼ 31.57▲
MA20 31.69▲ 31.63▲ 31.63▲ 32.14▼ 31.51▲
MA50 30.81▲ 30.61▲ 30.59▲ 31.51▲ 30.82▲
MA100 29.43▲ 29.16▲ 29.08▲ 31.46▲ 30.00▲
MA200 N/A     N/A     N/A     30.82▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.010▲ 0.024▲ 0.022▲ -0.069▼ 0.043▲
RSI 60.591▲ 60.638▲ 60.603▲ 46.242▼ 53.102▲
STOCH 86.977▲ 89.279▲ 89.279▲ 29.225     85.063▲
WILL %R -6.832▲ -6.627▲ -6.627▲ -100.000▼ -34.093    
CCI 75.475     95.723     95.723     -221.368▼ 55.286    
Latest Filters Detected On CAMX
RSI $CAMX RSI(14) Crossed Below 50 Set Alert
MA $CAMX Price Crossed Below MA(26) Set Alert
MA $CAMX Price Crossed Below MA(7) Set Alert
▼ BREAK $CAMX Price Breaks 10 Days Low Set Alert
CDL $CAMX Doji Candlestick Pattern Detected Set Alert
Advisors Inner Circle Fund - Cambiar Aggressive Value ETF News
Camurus increases share capital after employee stock option exercise
Monday, December 29, 2025 10:32 PM
Camurus AB ( ($SE:CAMX) ) has shared an announcement. Camurus has reported a minor increase in its share capital after employees exercised 7,350 ...
Camurus' Oczyesa Receives Positive CHMP Opinion For Acromegaly Treatment
Friday, April 25, 2025 08:43 AM
(RTTNews) - Camurus (CAMX), Friday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending market authorization of ...
Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients
Sunday, July 14, 2024 11:47 PM
Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1≤1xULN) vs SoC at baseline Continuous improvement of acromegaly symptom ...
CAMX historical stock data
date open high low close volume
30/12/25 31.714 31.714 31.714 31.714 61
29/12/25 32.164 32.164 32.164 32.164 100
26/12/25 32.247 32.247 32.247 32.247 100
24/12/25 32.2192 32.2192 32.2192 32.2192 16
23/12/25 32.1243 32.1243 32.1243 32.1243 16
22/12/25 32.2239 32.2239 32.2239 32.2239 74
19/12/25 32.12 32.17 32.017 32.017 29,800
18/12/25 32.226 32.2699 32.0585 32.0585 587
17/12/25 32.0532 32.0532 32.0532 32.0532 14
16/12/25 32.321 32.321 32.321 32.321 100
Quote Details
52wk Low:26.45
52wk High:32.66
Vol:61
Avg Vol(3m):14.3K
1Y Chng:+7.01%
1M Chng:+3.86%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00